Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.

about

Adoptive immunotherapy against sarcomas.

P2860

Q38291193-05C54D8A-EB94-47C1-BC2C-4050A4DB52A1

P2860

Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.

Item

http://www.wikidata.org/entity/Q40259357

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Generation of tumour-specific ...... ngs of patients with melanoma.

@en

type

Item

label

Generation of tumour-specific ...... ngs of patients with melanoma.

@en

prefLabel

Generation of tumour-specific ...... ngs of patients with melanoma.

@en

P1476

Generation of tumour-specific ...... ings of patients with melanoma

@en

P2093

C Traversari

http://www.w3.org/2001/XMLSchema#string

I Lionello

http://www.w3.org/2001/XMLSchema#string

K F Bradstock

http://www.w3.org/2001/XMLSchema#string

M Marangolo

http://www.w3.org/2001/XMLSchema#string

S Tanzarella

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.

CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

P2888

sj.bjc.6603243

P304

181-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603243

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Russo

Yi-Chiao Li

David J Gottlieb

P577

2006-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6964530

http://www.w3.org/2001/XMLSchema#string

P698

16819544

http://www.w3.org/2001/XMLSchema#string

P921

sibling

P932

2360612

http://www.w3.org/2001/XMLSchema#string

Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.

about

P2860

P2860

Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932